Importantly, DNA-PKcs is frequently overexpressed or hyperactivated in multiple malignancies, such as nasopharyngeal carcinoma [11], breast cancer [12], and gastric cancer [13], with preclinical studies demonstrating that its inhibition effectively suppresses tumor growth. Here, PRKDC is linked to neoplasm.